Gregory F Brooks

USPTO Granted Patents = 13 (Patent Applications = 11)

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 3 (Patent Applications = 9)

Average Co-Inventor Count = 1.6

ph-index = 5

Forward Citations = 274(Granted Patents)

Company Filing History:

Years Active: 2002-2023

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11826405 - Neurotoxin compositions for use in treating headache (2023-11-28),

2. 9492513 - Methods for treatment of hip and groin pain associated with femoroacetabular impingement (FAI) (2016-11-15),

3. 7811586 - Methods for alleviating testicular pain (2010-10-12),

4. 7794386 - Methods for facilitating weight loss (2010-09-14),

5. 7494654 - Compositions and methods for treating cardiovascular conditions with botulinum toxin (2009-02-24),

6. 7468188 - Multi-step therapy for injured muscles (2008-12-23),

7. 7223399 - [object Object] (2007-05-29),

8. 7140371 - Surface topography method for determining effects of a botulinum toxin upon a muscle and for comparing botulinum toxins (2006-11-28),

9. 7108857 - Therapy for injured muscles (2006-09-19),

10. 7048927 - Botulinum neurotoxin eluting stent (2006-05-23),

11. 6955813 - Therapy for injured muscles (2005-10-18),

12. 6767544 - Methods for treating cardiovascular diseases with botulinum toxin (2004-07-27),

13. 6423319 - Methods for treating muscle injuries (2002-07-23),

Title: Gregory F Brooks: Innovator in Neurotoxin Compositions

Introduction

Gregory F Brooks is a prominent inventor based in Irvine, CA, known for his significant contributions to the field of neurotoxin compositions. With a total of 13 patents to his name, Brooks has made remarkable advancements in medical treatments, particularly for headache and hip pain.

Latest Patents

Among his latest patents, Brooks has developed neurotoxin compositions specifically designed for treating headaches. These compositions and methods aim to alleviate the discomfort associated with this common ailment. Additionally, he has created methods for treating hip and groin pain related to femoroacetabular impingement (FAI). This innovative approach involves the local administration of a clostridial derivative, such as a botulinum toxin, to the hip capsule and surrounding muscle, providing relief to patients suffering from FAI.

Career Highlights

Throughout his career, Gregory F Brooks has worked with notable companies, including Allergan, Inc. and Allergan Sales, Inc. His experience in these organizations has allowed him to refine his expertise in neurotoxin applications and contribute to the development of effective treatment methods.

Collaborations

Brooks has collaborated with esteemed colleagues, including Stephen Donovan and Kei Roger Aoki. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of medical treatments.

Conclusion

Gregory F Brooks stands out as a leading inventor in the realm of neurotoxin compositions, with a focus on improving patient care through innovative treatments. His work continues to impact the medical community positively, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.